首页> 外文会议>Conference on Cognitive Sciences, Genomics and Bioinformatics >Diabetes Type 2 as a Risk Factor of Neurodegeneration Development and Cognitive Impairment in db/db Mice
【24h】

Diabetes Type 2 as a Risk Factor of Neurodegeneration Development and Cognitive Impairment in db/db Mice

机译:2型糖尿病是db / db小鼠神经退行性发展和认知障碍的危险因素

获取原文

摘要

Diabetes T2 with insulin resistance is a serious disease all over the world with a tendency to steady increase the number of cases and a risk factor of neurodegenerative diseases development, among them firstly Alzheimer’s disease. The aim of this study was to investigate behavior and general characteristic of genetic model of diabetes T2 mice db/db, trying to reveal beginning of development early symptoms of neurodegeneration development and characteristic of symptoms of diabetes T2 during treatment by liraglutide or autophagy inducer trehalose. Mice age was 3 and 5 months. Db/db mice had an increase in body weight, which progressed with age, a decrease in brain mass. Blood glucose levels were increased in db/db mice. Treatment with trehalose or liraglutide reduces its level. Db/db mice were characterized by decrease of overall orientation-exploratory and locomotor activities, increase in anxiety in the open field test. Liraglutide treatment showed positive change in open field test in db/db mice. Passive avoidance test revealed significant decrease in motivation, locomotor and exploratory activity, decreased learning in db/db mice. Db/db mice of both ages were characterized by an increase in the relative number of PMN and monocytes and a decrease in the number of lymphocytes, indicating an inflammatory response. Treatment with trehalose or liraglutide restored these indicators. Thus, the identified behavioral changes in db/db mice reflected the development of neurodegeneration signs. Some positive effects of liraglutide on behavioral processes have been shown. Trehalose and liraglutide reduced blood glucose levels and the severity of the inflammatory response.
机译:具有胰岛素抵抗的糖尿病T2是全世界的一种严重疾病,其趋势是稳定增加病例数和神经退行性疾病发展的危险因素,其中首先是阿尔茨海默氏病。这项研究的目的是调查糖尿病T2小鼠db / db的行为和遗传模型的一般特征,试图揭示在利拉鲁肽或自噬诱导剂海藻糖治疗期间神经退行性发展的早期发展症状和糖尿病T2症状的特征。小鼠年龄分别为3个月和5个月。 db / db小鼠体重增加,随年龄增长,脑质量下降。 db / db小鼠的血糖水平升高。用海藻糖或利拉鲁肽治疗可降低其水平。 Db / db小鼠的特征是在探索野外的活动中总体定向探索活动和运动活动减少,焦虑增加。利拉鲁肽治疗在db / db小鼠的野外试验中显示出积极的变化。被动回避测试显示db / db小鼠的动机,运动和探索活动显着减少,学习减少。两种年龄的Db / db小鼠的特征都是PMN和单核细胞的相对数目增加,而淋巴细胞的数目减少,表明有炎症反应。用海藻糖或利拉鲁肽治疗可恢复这些指标。因此,在db / db小鼠中确定的行为变化反映了神经退行性体征的发展。已显示利拉鲁肽对行为过程的一些积极作用。海藻糖和利拉鲁肽降低了血糖水平,降低了炎症反应的严重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号